Suppr超能文献

青光眼轴突损伤信号与分隔损伤反应。

Axon injury signaling and compartmentalized injury response in glaucoma.

机构信息

Department of Ophthalmology, University of Rochester Medical Center, Rochester, NY, USA; Neuroscience Graduate Program, University of Rochester Medical Center, Rochester, NY, USA.

Department of Ophthalmology, University of Rochester Medical Center, Rochester, NY, USA; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA; The Center for Visual Sciences, University of Rochester, Rochester, NY, USA.

出版信息

Prog Retin Eye Res. 2019 Nov;73:100769. doi: 10.1016/j.preteyeres.2019.07.002. Epub 2019 Jul 10.

Abstract

Axonal degeneration is an active, highly controlled process that contributes to beneficial processes, such as developmental pruning, but also to neurodegeneration. In glaucoma, ocular hypertension leads to vision loss by killing the output neurons of the retina, the retinal ganglion cells (RGCs). Multiple processes have been proposed to contribute to and/or mediate axonal injury in glaucoma, including: neuroinflammation, loss of neurotrophic factors, dysregulation of the neurovascular unit, and disruption of the axonal cytoskeleton. While the inciting injury to RGCs in glaucoma is complex and potentially heterogeneous, axonal injury is ultimately thought to be the key insult that drives glaucomatous neurodegeneration. Glaucomatous neurodegeneration is a complex process, with multiple molecular signals contributing to RGC somal loss and axonal degeneration. Furthermore, the propagation of the axonal injury signal is complex, with injury triggering programs of degeneration in both the somal and axonal compartment. Further complicating this process is the involvement of multiple cell types that are known to participate in the process of axonal and neuronal degeneration after glaucomatous injury. Here, we review the axonal signaling that occurs after injury and the molecular signaling programs currently known to be important for somal and axonal degeneration after glaucoma-relevant axonal injuries.

摘要

轴突变性是一个主动的、高度受控的过程,有助于有益的过程,如发育性修剪,但也有助于神经退行性变。在青光眼,眼内压升高通过杀死视网膜的输出神经元,即视网膜神经节细胞(RGC),导致视力丧失。已经提出了多种过程来促进和/或介导青光眼的轴突损伤,包括:神经炎症、神经营养因子的丧失、神经血管单元的失调以及轴突细胞骨架的破坏。虽然青光眼 RGC 损伤的激发因素很复杂,而且可能具有异质性,但轴突损伤最终被认为是驱动青光眼神经退行性变的关键损伤。青光眼神经退行性变是一个复杂的过程,多个分子信号有助于 RGC 体损失和轴突变性。此外,轴突损伤信号的传播很复杂,损伤会触发体和轴突区的退化程序。使这个过程更加复杂的是涉及到多种已知参与青光眼损伤后轴突和神经元变性过程的细胞类型。在这里,我们综述了损伤后发生的轴突信号转导以及目前已知对青光眼相关轴突损伤后体和轴突变性很重要的分子信号转导程序。

相似文献

1
Axon injury signaling and compartmentalized injury response in glaucoma.青光眼轴突损伤信号与分隔损伤反应。
Prog Retin Eye Res. 2019 Nov;73:100769. doi: 10.1016/j.preteyeres.2019.07.002. Epub 2019 Jul 10.
2
Autophagy in axonal degeneration in glaucomatous optic neuropathy.青光眼视神经病变轴突变性中的自噬作用。
Prog Retin Eye Res. 2015 Jul;47:1-18. doi: 10.1016/j.preteyeres.2015.03.002. Epub 2015 Mar 26.

引用本文的文献

9
Glaucoma and microglia-induced neuroinflammation.青光眼与小胶质细胞诱导的神经炎症
Front Ophthalmol (Lausanne). 2023 Feb 27;3:1132011. doi: 10.3389/fopht.2023.1132011. eCollection 2023.

本文引用的文献

2
SARM: From immune regulator to cell executioner.SARM:从免疫调节剂到细胞杀手。
Biochem Pharmacol. 2019 Mar;161:52-62. doi: 10.1016/j.bcp.2019.01.005. Epub 2019 Jan 8.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验